Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparative Evaluation of the Safety and Effectiveness of Crisaborole Ointment (2%) Versus Tacrolimus Ointment (0.1%) for the Topical Treatment of Atopic Dermatitis

NCT07437534 is registered in ClinicalTrials.gov with Hayat Abad Medical Complex, Peshawar as lead sponsor.

NCT NCT07437534
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07437534 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparative Evaluation of the Safety and Effectiveness of Crisaborole Ointment (2%) Versus Tacrolimus Ointment (0.1%) for the Topical Treatment of Atopic Dermatitis
Lead sponsor
Hayat Abad Medical Complex, Peshawar
Phase
Phase 4
Overall status
Not yet recruiting
Start date
March 1, 2026
Completion date
August 30, 2026
Enrollment
148 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

atopic dermatitis